MY01

Canada - Montreal, Quebec

• 13/04/2023
• Unknown
• $12,500,000

MY01 is a state-of-the-art medical device geared towards aiding in the detection of Compartment Syndrome (CS); a limb-threatening muscle condition that occurs within 48 hours following trauma.
Currently, ACS is diagnosed based on subjective and unreliable outcomes like pain (known as 6 P’s), which when present cannot confirm the diagnosis in time for effective intervention. This leads to increased complications (muscle necrosis/amputation) and costs the US healthcare system more than $2.25 B annually.
MY01 is capitalizing on a proven correlation between sustained increase in Intramuscular pressures and ACS for objective, early diagnosis. MY01 operationalizes muscular pressure monitoring into a simple, accurate single-use device.
MY01. The simple solution to a dangerous problem.

Engineered by NXTSENS

Related People

Charles AllanFounder

Canada - Montreal, Quebec

Charlie is passionate about using really small things to solve big problems. This fascination began in school; during undergrad, he helped build a microfluidic pump for an implantable therapeutic for glaucoma.

He is lucky to have been born into a loving family of successful entrepreneurs (mom, dad, uncles, grandparents and their friends) who helped foster the ability to create teams that can transform problems into solutions.

During his master's, he helped form a team that developed micro solutions, which led to the formation of three companies (MY01, Stathera and Nxtsens), all of which are growing today.

LinkedIn https://www.linkedin.com/in/charlesallanmy01/